CNBC's Meg Tirrell gives a report on Aerie Pharmaceuticals and why biotech investing is tricky.» Read More
CNBC's Meg Tirrell reports on a new scientific discovery for the more than $1.7 billion U.S. business of in vitro fertilization. Robert Frank provides insight.
Google Glass might have another purpose than just entertaining. Dr Horng from Boston said that it helped saved a patient's life last January.
CNBC contributor Barbara Ryan provides insight into new guidelines from the World Health Organization, which strongly endorses two new hepatitis c drugs.
The scientific effort to inform the public about landslide risks often run head-on into powerful economic interests.
On Autism Awareness Day, Pulitzer Prize-winning journalist and author Ron Suskind shared what he's learned from dealing with his youngest son's struggles with the condition.
The FTC has sued pharmaceutical companies $1 billion for delaying the sale of cheaper medicines after patents on brand-name drugs may have expired.
CNBC's Sue Herera speaks with teen inventor Ann Makosinski who took top honors in the Google Science fair for her battery free flashlight, powered by the heat of a person's hand.
CNBC's Sheila Dharmarajan reports 15 percent of high school aged children are diagnosed with ADHD, or attention deficit hyperactivity disorder.
Dr. Richard Saul wrote a book called "ADHD Does Not Exist." Saul is certain attention ADHD, or attention deficit hyperactivity disorder exists only in its symptoms. The condition does not exist.
Sam Isaly of OrbiMed Advisors, explains why he likes the new products of Regeneron, and why he expects Intermune to go higher.
If you've been wanting to abandon your cubicle to get your own office, there are good scientific excuses that may convince your boss.
Scientists are working to ensure astronauts don't die of dehydration. Now those solutions could ease futures droughts on earth.
Scientists have found a way to reprogram mature animal cells back into an embryonic-like state that allows them to generate many types of tissue.
Neurocrine Biosciences' president and CEO Kevin Gorman, Ph. D., provides insight on clinical trials for its tardive dyskinesia treatment.
The U.S. remains woefully underprepared for future polar vortexes, Bill Nye, "The Science Guy," told CNBC on Tuesday.
Bill Nye, The Planetary Society executive director, discusses the dangerous conditions of the "polar vortex" and the risk extremely cold weather poses to machines and our own bodies.
Tech veterans Kara Swisher and Walt Mossberg of Revere Digital discuss the launch of "Re/code," a reincarnation of "All Things D." Re/code also signed a content agreement with NBC News group to partner on technology coverage.
Nineteen-year-old Parker Liautaud talked to CNBC on Thursday live during his trek from the coast of Antarctica to the South Pole.
Parker Liautaud, Willis Resilience Expedition leader, has traveled to Antarctica to conduct research to better understand climate change and to raise awareness of global warming. CNBC's Carl Quintanilla reports.
The "Big 14" maintenance issues that NASA faces occasionally during space station operations is not a life-threatening emergency. NBC news reports.